Critical Insights on Biopharmaceutical Accountability

This chapter examines the troubling state of the biopharmaceutical industry, focusing on COVID-19 vaccine concerns and the influence of profit-driven motives. It also tackles the implications of recent legal battles over Pfizer documents and underscores the necessity for greater transparency and accountability in pharmaceutical practices.